Your session is about to expire
← Back to Search
Intervention A + site 6MWT administration for Peripheral Arterial Disease
N/A
Waitlist Available
Led By Connie Hess, MD
Research Sponsored by Colorado Prevention Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 and 12 months
Awards & highlights
Study Summary
This trial will test whether a team-based approach to treating peripheral artery disease, using a strict lipid reduction program, can improve patient outcomes. If successful, this program could be implemented system-wide.
Eligible Conditions
- Peripheral Arterial Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 and 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 and 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Month 12 LDL-C
Secondary outcome measures
Month 6 LDL-C
Other outcome measures
Biomarker levels
Correlation between venipuncture and dried dried blood spots
Distance Walked
+5 moreTrial Design
4Treatment groups
Active Control
Group I: Intervention A + site 6MWT administrationActive Control1 Intervention
Intervention A subjects will receive a vascular care team approach to care including pharmacy and healthcare provider assistance with medication adherence.
6-Minute Walk Test (6MWT) will be administered by site staff.
Group II: Intervention A + CPC EQuIP 6MWT administrationActive Control1 Intervention
Intervention A subjects will receive a vascular care team approach to care including pharmacy and healthcare provider assistance with medication adherence.
6-Minute Walk Test (6MWT) will be administered by CPC EQuIP staff.
Group III: Intervention B + site 6MWT administrationActive Control1 Intervention
Intervention B will receive standard care augmented with a single consultation with a Vascular Medicine physician who will provide the treating doctor with a personalized risk assessment for the patient and a summary of the 2018 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on Management of Blood.
6-Minute Walk Test (6MWT) will be administered by site staff.
Group IV: Intervention B + CPC EQuIP 6MWT administrationActive Control1 Intervention
Intervention B will receive standard care augmented with a single consultation with a Vascular Medicine physician who will provide the treating doctor with a personalized risk assessment for the patient and a summary of the 2018 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on Management of Blood.
6-Minute Walk Test (6MWT) will be administered by CPC EQuIP staff.
Find a Location
Who is running the clinical trial?
Colorado Prevention CenterLead Sponsor
12 Previous Clinical Trials
22,468 Total Patients Enrolled
4 Trials studying Peripheral Arterial Disease
6,797 Patients Enrolled for Peripheral Arterial Disease
Connie Hess, MDPrincipal InvestigatorCPC Clinical Research
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment still open for this research endeavor?
"This clinical trial is no longer accepting patients, as evidenced by the last update to its information on clinicaltrials.gov being November 9th 2022. Nevertheless, there are still 216 other trials that may be recruiting individuals right now."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger